诊断学理论与实践

诊断学理论与实践 >

2021 , Vol. 20 >Issue 04: 349 - 355

DOI: https://doi.org/10.16150/j.1671-2870.2021.04.004

国内外学术动态

回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读

展开
  • 上海交通大学医学院附属瑞金医院心脏科,上海 200025

收稿日期: 2021-08-09

  网络出版日期: 2021-08-25

收起

本文引用格式

施仲伟 . 回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021 , 20(04) : 349 -355 . DOI: 10.16150/j.1671-2870.2021.04.004

参考文献

[1] Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action[J]. J Am Coll Cardiol, 2020,76(25):2980-2981.
[2] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020, 396(10258):1204-1222.
[3] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disea-se Study 2019[J]. Lancet,2020, 396(10258):1223-1249.
[4] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol,2020, 76(25):2982-3021.
[5] Vekemans J, Gouvea-Reis F, Kim JH, et al. The path to group a Streptococcus Vaccines: World Health Organization research and development technology roadmap and preferred product characteristics[J]. Clin Infect Dis, 2019,69(5):877-883.
[6] Yu K, Lv J, Qiu G, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study[J]. Lancet Glob Health, 2020,8(3):e430-e439.
[7] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021,36(6):521-545.
[8] Moran A, Zhao D, Gu D, et al. The future impact of popu-lation growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Po-licy Model-China[J]. BMC Public Health, 2008,8:394.
[9] Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International[J]. J Am Coll Cardiol, 2019,73(24):3135-3147.
[10] Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nat Rev Cardiol, 2019,16(4):203-212.
[11] Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013,381(9882):1987-2015.
[12] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019,394(10204):1145-1158.
[13] Zhao D. Epidemiological features of cardiovascular di-sease in Asia[J]. JACC: Asia, 2021,1(1):1-13.
[14] 李镒冲, 刘世炜, 曾新颖, 等. 1990-2016年中国及省级行政区心血管病疾病负担报告[J]. 中国循环杂志, 2019,34(8):729-740.
[15] Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global Burden of disease study[J]. JAMA Cardiol, 2019,4(4):342-352.
[16] 王文, 朱曼璐, 王拥军, 等. 《中国心血管病报告2012》概要[J]. 中国循环杂志, 2013,28(6):408-412.
[17] Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities[J]. Stroke, 2006,37(1):63-68.
[18] Zhang G, Yu C, Zhou M, et al. Burden of ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study[J]. BMC Cardiovasc Disord,2018, 18(1):18.
[19] Dai H, Much AA, Maor E, et al. Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020:qcaa076.
[20] Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health, 2013,1(5):e259-e281.
[21] GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med,2018, 379(25):2429-2437.
[22] Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives[J]. Int J Cardiol Heart Vasc, 2014,6:25-31.
[23] GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019[J]. Lancet,2021, 397(10292):2337-2360.
[24] Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults[J]. Int J Cardiol, 2018,260:196-203.
[25] Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000[J]. N Engl J Med, 2007,356(23):2388-2398.
[26] Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000[J]. Circulation,2004, 109(9):1101-1107.
[27] Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017,69(9):1116-1125.
Options
文章导航

/

〈 〉